BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17879014)

  • 1. [To the contribution by Claus Niederau. New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].
    Lelgemann M; Ollenschläger G
    Med Klin (Munich); 2007 Sep; 102(9):761-2. PubMed ID: 17879014
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 3. [German guidelines on diagnosis and therapy of hepatitis B].
    Wedemeyer H; Cornberg M; Protzer U; Berg T; Dollinger MM
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1775-82. PubMed ID: 17713890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B virus carriers; natural course, diagnostic approach and treatment.
    Ranjan P; Aggarwal R
    Trop Gastroenterol; 2005; 26(2):58-65. PubMed ID: 16225046
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus escape mutants induced by antiviral therapy.
    Sheldon J; Soriano V
    J Antimicrob Chemother; 2008 Apr; 61(4):766-8. PubMed ID: 18218641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B escape mutant reactivation in a renal transplant patient.
    Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
    J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
    Degertekin B; Lok AS
    J Hepatol; 2008 Jun; 48(6):892-4. PubMed ID: 18433924
    [No Abstract]   [Full Text] [Related]  

  • 10. Revisiting the treatment recommendations for chronic hepatitis B.
    Chan HL
    Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B virus genotypes: natural history and implications for treatment.
    Yuen MF; Lai CL
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):321-8. PubMed ID: 19072424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
    Li GY; Sheng JL; Huang HJ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):133-5. PubMed ID: 18574538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability of hepatitis B virus and response to antiviral therapy.
    Liu CJ; Kao JH
    Antivir Ther; 2008; 13(5):613-24. PubMed ID: 18771045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries.
    Akbar SM; Hiasa Y; Mishiro S; Onji M
    Expert Opin Pharmacother; 2009 Jul; 10(10):1605-14. PubMed ID: 19496738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
    Erhardt A; Göbel T; Ludwig A; Lau GK; Marcellin P; van Bömmel F; Heinzel-Pleines U; Adams O; Häussinger D
    J Med Virol; 2009 Oct; 81(10):1716-20. PubMed ID: 19697400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis B virus infected health care workers based on HBV DNA levels.
    Schalm SW; Buster EH
    J Clin Virol; 2003 Aug; 27(3):231-4. PubMed ID: 12878085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis B in clinical practice].
    Petersen J
    Med Monatsschr Pharm; 2011 Nov; 34(11):402-14; quiz 415-6. PubMed ID: 22165496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
    Wiegand J; Hasenclever D; Tillmann HL
    Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.